[DOI] [PubMed] [Google Scholar] 111.Bogliun G., Marzorati L., Marzola M., Miceli M.D., Cantu M.G., Cavaletti G
Legitimate programs share traits: licensed clinicians, state-licensed pharmacy partners, clinical evaluation before any prescription, and transparent pricing
The BALANCE model was originally scheduled to take effect in January 2027 and would have allowed Medicare Part D sponsors to decide whether to cover GLP-1s for weight loss
The Breakdown: What Does a B12 Injection Actually Cost
Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands